A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...
The Progressive Fibrosing Interstitial Lung Disease (PF-ILD) market is currently valued at USD 4,742.2 Million in 2023 and is ...
The CEO of pharmaceuticals giant Roche has urged authorities to block the takeover of contract drug manufacturer Catalent by ...
Tracking patient response to DMARD therapy has the potential to improve remission, but multiple barriers must be overcome ...
An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of ...
The Roundup covers notable class action decisions from federal appellate courts and notable Supreme Court class action cert petitions.
Medpage Today on MSN2d
Potentially Large Cost Savings With Home-Based OCT for Neovascular AMDCHICAGO -- An artificial intelligence (AI)-based study of home monitoring for neovascular age-related macular degeneration ...
At the forefront of poultry production, USPOULTRY's 2024 Live Production, Welfare and Biosecurity Seminar — held in Tucker, ...
Progressive pulmonary fibrosis (PPF) is an increasingly recognised condition, defined in 2022 to address the progression of ...
Hosted by Boehringer Ingelheim, the ‘CRM Summit’, an expert engagement forum, and the ‘IMETA CRM Discussions for EXperts (MEDEX CRM)’, a scientific expert meeting, brought together healthcare ...
GoodRx announced a new partnership with Boehringer Ingelheim to provide discounts for a biosimilar to rheumatoid arthritis drug Humira Thursday, adding to an increasingly competitive market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback